Gameto, a biotechnology startup solving the problem of accelerated ovarian aging to change the trajectory of women’s health and equality, today announced that it has raised a $20M in Series A funding led by Future Ventures, with participation from Bold Capital Partners, Lux Capital, Plum Alley, TA Ventures, Overwater Ventures, Robert Nelsen and Anne Wojcicki. Gameto also raised $3M in Seed funding in March 2020 from a range of notable investors…
Twentyeight Health, a telehealth company increasing access to sexual and reproductive care for women from underserved communities, has announced that it is now accepting Medicaid in Georgia for birth control. “As a Georgia resident and physician, I’ve seen firsthand the difficulty women can have accessing birth control for myriad reasons, from not being able to get to the doctor to get a…
Mirvie, a pioneer in predicting unexpected pregnancy complications, has announced the publication of a study in Nature proving the proprietary Mirvie RNA platform is first to predict unexpected complications by revealing the underlying biology of each pregnancy. The research analyzed the largest and most diverse dataset of maternal transcriptomes to date. The platform opens a new window into pregnancy health for women to act…
Reproductive Health company Natural Cycles, known for its contraceptive mobile app, has teamed up with renowned institutions and clinicians in the field of women’s health to research the relationship between COVID-19 vaccines and the menstrual cycle. The findings have now been published in Obstetrics & Gynecology and analyzed the cycles of nearly 4,000 US-based Natural Cycles users to determine if COVID-19 vaccines changed…
The World Bank Group and the Consumer Technology Association (CTA) have announced the winners of The Global Women’s HealthTech Awards, recognizing innovative startups that leverage tech to improve women’s health and safety in emerging markets. The winning startups selected by a panel of industry experts are Antiva Biosciences, InnAccel, NIRAMAI, and UE LifeSciences. The Awards attracted over 70 companies from 35 countries, which submitted their innovative…
Welcome! You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet and would like to find out more about our Inner Circle program or sign up, click here.
Eggschain, the first patented supply chain system that combines blockchain and genetics to bring medical grade information and data to individuals undergoing IVF in a secure, transparent and universally trackable format, is partnering with Boston IVF, one of the country’s most renowned fertility networks. The partnership will leverage Eggschain technology for cryogenic preservation of sperm for use in IVF and other fertility…
Future Fertility, a fertility technology company developing AI-enabled and non-invasive fertility solutions to optimize clinical decision making in fertility care and in vitro fertilization (IVF), today announced that it has successfully raised a Series A financing round. The investment was led by M Ventures, the corporate venture capital arm of Merck, with participation from Whitecap Venture Partners. Future Fertility was co-founded in…
